نتایج جستجو برای: tas

تعداد نتایج: 3073  

Journal: :Journal of clinical pathology 1997
S Kitchen F E Preston

BACKGROUND A number of instruments have been developed for determination of prothrombin time (PT) and International Normalised Ratio (INR) at locations not limited to central laboratories. AIM To evaluate one such portable instrument, the Thrombolytic Assessment System (TAS), which can be used in a near-patient setting. METHODS Samples from 20 normal subjects and 48 patients treated with wa...

2015
Hyunsu Lee Jae-Ho Lee Dae-Kwang Kim In-Jang Choi Ilseon Hwang Yu-Na Kang Shin Kim

Colorectal cancer is a heterogeneous disorder than arises via multiple distinct pathways, from tubular adenomas (TAs) and sessile serrated adenomas (SSAs), which are clinically, morphologically, and molecularly different. We examined PIK3CA amplification in colorectal precancerous legions, including TAs and SSAs. DNA was isolated from paired normal and tumoral tissues in 64 TAs and 32 SSAs. PIK...

2018
Song Han David H. Gonzalo Michael Feely Carlos Rinaldi Sayali Belsare Haiyan Zhai Krishan Kalra Michael H. Gerber Christopher E. Forsmark Steven J. Hughes

The biology of tumor-associated stroma (TAS) in pancreatic ductal adenocarcinoma (PDAC) is not well understood. The paradoxical observation that stroma-depletion strategies lead to progression of PDAC reinforced the need to critically evaluate the functional contribution of TAS in the initiation and progression of PDAC. PDAC and TAS cells are unique in their expression of specific miRNAs, and t...

Journal: :Molecular pharmacology 2008
Makoto Yoshida Yasuaki Kabe Tadashi Wada Akira Asai Hiroshi Handa

6-((2-(Dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)-quinolin-7-one dihydrochloride (TAS-103) is a quinoline derivative that displays antitumor activity in murine and human tumor models. TAS-103 has been reported to be a potent topoisomerase II poison. However, other studies have indicated that cellular susceptibility to TAS-103 is not correlated with topoisomerase II expression. Becaus...

2017
Rakshith Rajashekar

Transmit antenna (TA) subset selection (TAS) is a well known multiple-input multiple-output technique that exploits the channel state information (CSI) at the transmitter in order to improve the attainable bit error rate (BER) performance. The extensive study of TAS in the context of spatial modulation (SM) has recently revealed that a significant performance gains are attainable compared to SM...

2010
Stephen Nicol Andrew Bowie Simon Jarman Delphine Lannuzel Klaus M Meiners Pier van der Merwe

Department of the Environment, Water, Heritage and the Arts, Australian Antarctic Division, 203 Channel Highway, Kingston, Tas. 7050, Australia; Antarctic Climate and Ecosystems Cooperative Research Centre, University of Tasmania, Private Bag 80, Hobart, Tas. 7001, Australia; Department of the Environment, Water, Heritage and the Arts, Australian Antarctic Division, Australian Marine Mammal Cen...

2016
Yoshikazu Hasegawa Takayo Ota Hiroshi Tsukuda Tomohiro Suzumura Masahiro Fukuoka

A 59-year-old woman, diagnosed with advanced rectal cancer, presented with a low-grade fever and dyspnea on exertion after the 2nd cycle of TAS-102. TAS-102 has promising efficacy in patients with metastatic colorectal cancer. A CT scan revealed mosaic patterns with bilateral ground-glass opacities. The drug lymphocyte stimulation test for TAS-102 was strongly positive and serum β-D glucan leve...

Journal: :Cancer research 2014
Naoya Mimura Teru Hideshima Toshiyasu Shimomura Rikio Suzuki Hiroto Ohguchi Ola Rizq Shohei Kikuchi Yasuhiro Yoshida Francesca Cottini Jana Jakubikova Diana Cirstea Gullu Gorgun Jiro Minami Yu-Tzu Tai Paul G Richardson Teruhiro Utsugi Atsushi Iwama Kenneth C Anderson

The PI3K/Akt pathway plays a crucial role in the pathogenesis of multiple myeloma (MM) in the bone marrow (BM) milieu. However, efficacy of selective and potent Akt inhibition has not yet been fully elucidated. In this study, we, therefore, examined the biologic impact of selective and potent Akt inhibition by a novel allosteric inhibitor TAS-117. TAS-117 induced significant growth inhibition, ...

2016
Hidenori Fujita Akira Gomori Yayoi Fujioka Yuki Kataoka Kenji Tanaka Akihiro Hashimoto Takamasa Suzuki Kenjiro Ito Tomonori Haruma Hiromi Yamamoto-Yokoi Naomoto Harada Motomu Sakuragi Nobuyuki Oda Kenichi Matsuo Masaki Inada Kazuhiko Yonekura

Approximately 25-40% of patients with lung cancer show bone metastasis. Bone modifying agents reduce skeletal-related events (SREs), but they do not significantly improve overall survival. Therefore, novel therapeutic approaches are urgently required. In this study, we investigated the anti-tumor effect of TAS-115, a VEGFRs and HGF receptor (MET)-targeted kinase inhibitor, in a tumor-induced bo...

Journal: :The oncologist 2010
August Zabernigg Eva-Maria Gamper Johannes M Giesinger Gerhard Rumpold Georg Kemmler Klaus Gattringer Barbara Sperner-Unterweger Bernhard Holzner

BACKGROUND Taste alterations (TAs) are a frequent but under-recognized treatment side effect in cancer patients undergoing chemotherapy (CT). CT regimens with different toxicity profiles may vary in their impact on TAs, but research on this topic is lacking. This study assesses the prevalence of TAs and their relation to sociodemographic and clinical variables, especially CT regimens. Furthermo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید